Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $22,734 | 707 | 87.6% |
| Travel and Lodging | $2,445 | 9 | 9.4% |
| Education | $685.22 | 8 | 2.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $101.84 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $4,183 | 45 | $0 (2024) |
| BIOTRONIK INC. | $3,609 | 65 | $0 (2024) |
| Boston Scientific Corporation | $2,029 | 54 | $0 (2024) |
| Amgen Inc. | $1,878 | 57 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,473 | 37 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $1,418 | 53 | $0 (2024) |
| PFIZER INC. | $1,004 | 54 | $0 (2024) |
| AngioDynamics, Inc. | $970.67 | 16 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $772.03 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $748.68 | 44 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,022 | 130 | Abbott Laboratories ($2,771) |
| 2023 | $3,463 | 92 | Abbott Laboratories ($886.24) |
| 2022 | $2,477 | 97 | BIOTRONIK INC. ($550.23) |
| 2021 | $2,861 | 83 | BIOTRONIK INC. ($884.56) |
| 2020 | $1,061 | 45 | Medtronic Vascular, Inc. ($186.45) |
| 2019 | $3,256 | 98 | BIOTRONIK INC. ($821.18) |
| 2018 | $4,108 | 101 | Medtronic Vascular, Inc. ($827.44) |
| 2017 | $2,719 | 79 | AngioDynamics, Inc. ($533.33) |
All Payment Transactions
725 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $5.59 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/19/2024 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/19/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/18/2024 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $132.96 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/10/2024 | AngioDynamics, Inc. | AURYON LASER SYSTEM 100-120 VAC (Device) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: PAD | ||||||
| 12/05/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/04/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $32.74 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/30/2024 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $41.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.24 | General |
| Category: Cardiovascular | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/20/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $5.95 | General |
| Category: General - Therapies_CRM | ||||||
| 11/19/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $589.48 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/15/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.01 | General |
| Category: Cardiovascular | ||||||
| 11/05/2024 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $18.28 | General |
| Category: Peripheral Intervention | ||||||
| 11/05/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/03/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $150.11 | General |
| Category: Lithoplasty | ||||||
| 11/03/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $35.68 | General |
| Category: Lithoplasty | ||||||
| 11/02/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $146.53 | General |
| Category: General - Catheters_PI | ||||||
| 10/30/2024 | Boston Scientific Corporation | VIGILANT X4 CRT-D (Device) | Food and Beverage | In-kind items and services | $5.70 | General |
| Category: VIGILANT_CRM | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $128.22 | General |
| Category: Cardiovascular | ||||||
| 10/29/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $88.34 | General |
| 10/29/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $88.33 | General |
| Category: Cardiology | ||||||
| 10/25/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $3.39 | General |
| Category: Cardiology | ||||||
| 10/24/2024 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $31.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 58 | 5,165 | 9,291 | $2.3M | $890,486 |
| 2022 | 51 | 5,319 | 9,121 | $2.4M | $971,560 |
| 2021 | 58 | 5,451 | 11,218 | $2.3M | $917,616 |
| 2020 | 61 | 5,494 | 11,737 | $2.4M | $917,595 |
All Medicare Procedures & Services
257 procedure records from CMS Medicare Utilization — Page 1 of 11
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 143 | 144 | $695,107 | $300,427 | 43.2% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 144 | 290 | $232,000 | $91,427 | 39.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 421 | 618 | $143,951 | $57,542 | 40.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 538 | 796 | $130,672 | $51,671 | 39.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 252 | 258 | $100,465 | $35,383 | 35.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 275 | 277 | $76,989 | $28,725 | 37.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 159 | 644 | $69,552 | $26,982 | 38.8% |
| 36478 | Laser destruction of incompetent vein of arm or leg using imaging guidance | Office | 2023 | 22 | 35 | $73,673 | $25,589 | 34.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 138 | 160 | $49,644 | $21,202 | 42.7% |
| 78434 | Nuclear medicine study of heart muscle blood flow by pet | Office | 2023 | 143 | 144 | $49,222 | $20,151 | 40.9% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 44 | 44 | $47,784 | $18,569 | 38.9% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 121 | 121 | $44,640 | $15,224 | 34.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 279 | 280 | $40,162 | $14,775 | 36.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 122 | 122 | $40,626 | $14,463 | 35.6% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 79 | 82 | $39,570 | $14,075 | 35.6% |
| 33228 | Removal and replacement of dual lead permanent pacemaker | Facility | 2023 | 44 | 44 | $32,409 | $12,444 | 38.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 124 | 173 | $25,696 | $10,899 | 42.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 176 | 182 | $25,839 | $9,572 | 37.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 68 | 71 | $26,608 | $9,565 | 35.9% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 27 | 54 | $11,610 | $8,918 | 76.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 27 | 29 | $24,334 | $8,675 | 35.6% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 96 | 137 | $19,344 | $7,851 | 40.6% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 119 | 133 | $21,334 | $6,479 | 30.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 541 | 605 | $21,772 | $6,217 | 28.6% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 114 | 281 | $17,332 | $5,574 | 32.2% |
About Dr. Kalpesh Solanki, DO
Dr. Kalpesh Solanki, DO is a Cardiovascular Disease healthcare provider based in Ocala, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245325570.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kalpesh Solanki, DO has received a total of $25,966 in payments from pharmaceutical and medical device companies, with $6,022 received in 2024. These payments were reported across 725 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($22,734).
As a Medicare-enrolled provider, Solanki has provided services to 21,429 Medicare beneficiaries, totaling 41,367 services with total Medicare billing of $3.7M. Data is available for 4 years (2020–2023), covering 257 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Ocala, FL
- Active Since 10/03/2006
- Last Updated 06/25/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1245325570
Products in Payments
- AVEIR (Device) $2,819
- Repatha (Biological) $1,442
- ELIQUIS (Drug) $1,417
- XARELTO (Drug) $1,409
- BIOMONITOR (Device) $840.10
- JARDIANCE (Drug) $772.03
- EVLT (Device) $607.40
- LifeVest (Device) $501.60
- PRALUENT (Drug) $482.83
- ENTRESTO (Drug) $458.89
- AURYON LASER SYSTEM 100-120 VAC (Device) $363.27
- BRILINTA (Drug) $340.62
- LIMFLOW SYSTEM (Device) $329.52
- Corlanor (Drug) $329.34
- JOT DX (Device) $325.91
- VERQUVO (Drug) $312.08
- Confirm Rx (Device) $308.80
- Vascepa (Drug) $307.93
- Reveal LINQ (Device) $293.75
- LEQVIO (Drug) $289.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Ocala
Dr. Celso Acevedo, Md, MD
Cardiovascular Disease — Payments: $162,222
Dr. Lan Luo, Md, MD
Cardiovascular Disease — Payments: $79,241
Hiroko Beck, Md, MD
Cardiovascular Disease — Payments: $46,884
Dr. Siva Gummadi, M.d, M.D
Cardiovascular Disease — Payments: $32,776
Dr. Gregory Vonmering, Md, MD
Cardiovascular Disease — Payments: $28,465
Dr. Rakesh Prashad, M.d, M.D
Cardiovascular Disease — Payments: $18,520